日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy

佐剂重组带状疱疹疫苗在接受乌帕替尼治疗的类风湿性关节炎患者中的免疫原性：一项随机对照试验子研究的 60 周结果

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2025-005521
Winthrop, Kevin L; Klaff, Justin; Penn, Sara K; Liu, Yanxi; García, Conrado; Mysler, Eduardo; Wells, Alvin F; Bu, Xianwei; Fish, Irina; Chen, Michael; Cunningham, Anthony L
微生物学
关节炎
疱疹
免疫/内分泌
发表日期：2025
文献求助 收藏

Health Disparities in Rheumatology in the United States

美国风湿病学领域的健康差异

期刊:Open Access Rheumatology-Research and Reviews
影响因子:2.3
doi:10.2147/OARRR.S493457
Wright, Grace C; Zueger, Patrick M; Copley-Merriman, Catherine; Khan, Shahnaz; Costello, Jessica; Krumbach, Alisha; Reddy, Priya; Tanjinatus, Oishi; Wells, Alvin F
发表日期：2025
文献求助 收藏

Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND

SELECT-BEYOND 研究显示，对于生物制剂治疗无效的活动性类风湿关节炎患者，upadacitinib 的长期疗效可持续性：长达 5 年的结果

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-004037
van Vollenhoven, Ronald F; Hall, Stephen; Wells, Alvin F; Meerwein, Sebastian; Song, Yanna; Tanjinatus, Oishi; Fleischmann, Roy
关节炎
SELE
发表日期：2024
文献求助 收藏

Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study

Upadacitinib治疗类风湿性关节炎患者的长期疗效和安全性：BALANCE-EXTEND开放标签扩展研究的最终结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00557-x
Kivitz, Alan; Wells, Alvin F; Vargas, Juan I; Baraf, Herbert S B; Rischmueller, Maureen; Klaff, Justin; Khan, Nasser; Li, Yihan; Carter, Kyle; Friedman, Alan; Durez, Patrick
关节炎
发表日期：2023
文献求助 收藏

Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists

远程医疗与银屑病关节炎：皮肤科医生和风湿病科医生的最佳实践和注意事项

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-022-06077-3
Gottlieb, Alice B; Wells, Alvin F; Merola, Joseph F
关节炎
银屑病
发表日期：2022
文献求助 收藏

Analysis of Operational Efficiency and Cost Differences between Local and General Anesthesia for Vitreoretinal Surgery

玻璃体视网膜手术中局部麻醉与全身麻醉的操作效率和成本差异分析

期刊:Healthcare
影响因子:2.7
doi:10.3390/healthcare10101918
Siddiqui, Mohammad Z; Chauhan, Muhammad Z; Stewart, Alvin F; Sallam, Ahmed B
发表日期：2022
文献求助 收藏

Development and Evaluation of a Risk-Adjusted Measure of Intraoperative Hypotension in Patients Having Nonemergent, Noncardiac Surgery

针对非紧急、非心脏手术患者，开发和评估一种经风险调整的术中低血压测量方法

期刊:Anesthesia and Analgesia
影响因子:3.8
doi:10.1213/ANE.0000000000005287
Christensen, Anna L; Jacobs, Ethan; Maheshwari, Kamal; Xing, Fei; Zhao, Xiaohong; Simon, Samuel E; Domino, Karen B; Posner, Karen L; Stewart, Alvin F; Sanford, Joseph A; Sessler, Daniel I
发表日期：2021
文献求助 收藏

Rural breast cancer survivors are able to maintain diet quality improvements during a weight loss maintenance intervention

农村乳腺癌幸存者在体重维持干预期间能够保持饮食质量的改善

期刊:Journal of Cancer Survivorship
影响因子:2.9
doi:10.1007/s11764-020-00951-2
Marchello, Nicholas J; Gibbs, Heather D; Sullivan, Debra K; Taylor, Mathew K; Hamilton-Reeves, Jill M; Beltramo, Alvin F; Befort, Christie A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study

预测肿瘤坏死因子-α抑制剂疗效不佳的分子特征反应分类器：NETWORK-004前瞻性观察研究

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00330-y
Cohen, Stanley; Wells, Alvin F; Curtis, Jeffrey R; Dhar, Rajat; Mellors, Theodore; Zhang, Lixia; Withers, Johanna B; Jones, Alex; Ghiassian, Susan D; Wang, Mengran; Connolly-Strong, Erin; Rapisardo, Sarah; Gatalica, Zoran; Pappas, Dimitrios A; Kremer, Joel M; Saleh, Alif; Akmaev, Viatcheslav R
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study

巴瑞替尼每日一次 2 mg 治疗活动性类风湿关节炎患者的长期疗效：两项为期 24 周的 III 期随机对照研究和一项长期扩展研究的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00317-9
Wells, Alvin F; Jia, Bochao; Xie, Li; Valenzuela, Guillermo J; Keystone, Edward C; Li, Zhanguo; Quebe, Amanda K; Griffing, Kirstin; Otawa, Susan; Haraoui, Boulos
关节炎
发表日期：2021
文献求助 收藏